No Picture
News

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

SAN DIEGO–(BUSINESS WIRE)–Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that the first patient has been […]

No Picture
News

Macomics Unveils its Lead First-in-Class Anti-Pan-LILRB Monoclonal Antibody Programme with Positive Pre-clinical Data Presented at AACR 2024

EDINBURGH, United Kingdom and CAMBRIDGE, United Kingdom, April 11, 2024 (GLOBE NEWSWIRE) — Macomics Ltd, a leader in macrophage drug discovery, has unveiled details of its lead programme, a first-in-class ligand independent-pan-LILRB monoclonal antibody for […]

ADVERTISEMENT — Advertise With Biotech Networks
BioSpace

Top 5 Companies Hiring in San Diego

Published: Apr 11, 2024 By Angela Gabriel Pictured: Buildings in downtown San Diego near the water/iStock, Sean Pavone Located in Biotech Beach, San Diego is one of California’s hottest hiring cities for biopharma roles, with […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Skye Bioscience Uplists to The Nasdaq Global Market

SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Parhelia Biosciences Announces the Launch of the Parhelia Spatial Station™ – A Revolutionary Sample Prep System for Spatial Biology

SAN DIEGO–(BUSINESS WIRE)–Parhelia Biosciences, a leader in spatial biology automation, is excited to announce the launch of the Parhelia Spatial Station at the American Association for Cancer Research Conference—a next-generation sample preparation platform designed to […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Opna Bio Presents Promising Preclinical Data in Multiple Myeloma with OPN-6602 and in Malignant Mesothelioma with OPN-9840 Showing Significant Tumor Growth Inhibition at the American Association of Cancer Research Annual Meeting

SAN DIEGO–(BUSINESS WIRE)–Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer therapeutics, presented promising preclinical data in two programs, OPN-6602, a dual EP300/CBP inhibitor in multiple myeloma, and OPN-9840, […]

ADVERTISEMENT — Advertise With Biotech Networks
News

How a new drug prototype regenerates lung tissue

A new study from Scripps Research and Calibr-Skaggs scientists provides pharmacological proof of concept for an upcoming phase 1 clinical trial. LA JOLLA, Calif., April 10, 2024 /PRNewswire/ — Pulmonary diseases are a leading cause […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024

FOSTER CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) — Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”), a clinical-stage precision oncology company developing a new class of cancer therapies identified by its Predictive Precision […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform

CARLSBAD, Calif., April 9, 2024 /PRNewswire/ — Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications announces the launch of its new multiplex […]

No Picture
News

AACR 2024: Brenus Pharma Unveils Promising and Robust Pre-clinical Efficacy Extrapolating Human Conditions with STC-1010

LYON, France–(BUSINESS WIRE)– #AACR2024–Brenus Pharma unveils groundbreaking results during the American Association Cancer Research (AACR) Annual meeting 2024 – San Diego (April 5-10). “Efficacy of the STC-10101 a new allogeneic cancer vaccine in different colorectal […]

No Picture
News

Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors

NEEDHAM, Mass., April 09, 2024 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced […]

ADVERTISEMENT — Advertise With Biotech Networks
News

Model Medicines Unveils Groundbreaking AI Drug Discovery Advances in New Chemistry and New Biology with Two New Preprint Papers

LA JOLLA, Calif., April 9, 2024 /PRNewswire/ — Model Medicines, a leading human health company specializing in generative AI-driven drug discovery, today announced the publication of two significant preprint papers on bioRxiv detailing major advances […]

No Picture
News

GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting

SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the latest findings of GFH547, an oral panRAS (ON) inhibitor, […]

No Picture
News

GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting

SHANGHAI and SAN DIEGO, April 9, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today unveiled the latest research findings of GFH375, an oral KRAS G12D […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Sanguine Biosciences Affirms Superior Quality of its Biospecimen Services Using VERIF.i®, Scientist.com’s Supplier Pre-assessment Program

SAN DIEGO–(BUSINESS WIRE)– #Compli–Sanguine Biosciences showcases quality of its biospecimen services with participation in VERIF.i® , Scientist.com’s supplier pre-assessment program. Click here to view original post Click Here to Publish/Feature Your Company or Product News […]

No Picture
News

Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024

SAN DIEGO–(BUSINESS WIRE)—- $CLDI #immunotherapy–Calidi Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at AACR 2024 Click here to view original post Click Here to […]